---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-23-002711"
form_type: "8-K"
ticker: "NUTX"
cik: "0001479681"
company_name: "Nutex Health Inc."
filed_at: "2023-03-02T23:59:59+00:00"
generated_at: "2026-06-18T14:56:48.383472+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Nutex Health reports FY2022 revenue of $219.3M, net loss of $424.8M on $398.1M goodwill impairment

## Summary
- Total revenue $219.3M for FY2022; Q4 revenue $53.7M; net loss attributable to Nutex $424.8M.
- Adjusted EBITDA $12.5M for FY2022; Q4 adjusted EBITDA loss of $5.9M.
- Net cash from operating activities $50.6M; cash and equivalents $34.3M at year-end.
- Goodwill impairment of $398.1M; warrant/option valuation revision reduced impairment by $10.3M.
- No Surprises Act reduced revenue by ~$29M in Q3 and $9.6M in H1 2022; company plans 19 new facilities by mid-2025.

## SEC filing metadata
- accession: 0001558370-23-002711
- form_type: 8-K
- ticker: NUTX
- cik: 0001479681
- company_name: Nutex Health Inc.
- filed_at: 2023-03-02T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1479681/000155837023002711/0001558370-23-002711-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1479681/000155837023002711/nutx-20230302x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-23-002711
- JSON: https://secwatch.observer/filing/0001558370-23-002711.json
- Plain text: https://secwatch.observer/filing/0001558370-23-002711.txt

## Key facts
- Earnings Releases
  Nutex Health Inc. reported the fiscal year ended December 31, 2022 results: revenue $219.3 million, net income Net loss attributable to Nutex Health Inc. of $424.8 million.
  - Period: the fiscal year ended December 31, 2022
  - Revenue: $219.3 million
  - Net income: Net loss attributable to Nutex Health Inc. of $424.8 million
  - Result: reported results
  source text: 99.1 to this Current Report on Form 8-K. --- EX-99.1 (EX-99.1) --- ​ ​ NUTEX HEALTH Inc. reports fourth quarter and Full YEAR 2022 financial results ​ ● Total revenue of $219.3 million for the year ended 2022 ● Net cash from operating activities of $50.6 million for the YEAR ended 2022 ● Company expects to open 19 NEW facilities by mid-2025 ​ HOUSTON, TX −
  evidence_url: https://www.sec.gov/Archives/edgar/data/1479681/000155837023002711/0001558370-23-002711-index.htm
- Earnings Releases
  Nutex Health Inc. reported the three months ended December 31, 2022 results: revenue $53.7 million, net income Net loss attributable to Nutex Health of $14.7 million.
  - Period: the three months ended December 31, 2022
  - Revenue: $53.7 million
  - Net income: Net loss attributable to Nutex Health of $14.7 million
  - Result: reported results
  source text: Financial Highlights for the Three Months Ended December 31, 2022: ● Total revenue of $53.7 million. ● Net loss attributable to Nutex Health of $14.7 million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1479681/000155837023002711/0001558370-23-002711-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.